Showing results (51-60 of 198) with videos related to
Sort By:
Pageof 20
Brain Pathology (Zurich, Switzerland)|March 9, 2011
Neprilysin protects against cerebral amyloid angiopathy and Aβ-induced degeneration of cerebrovascular smooth muscle cellsJames Scott Miners, Patrick Kehoe, Seth LoveTrends in Neurosciences|October 3, 2009
Angiotensins in Alzheimer's disease - friend or foe?Patrick G Kehoe, Scott Miners, Seth LoveActa Neuropathologica|September 1, 2005
Loss of perineuronal net N-acetylgalactosamine in Alzheimer's diseaseShabnam Baig, Gordon K Wilcock, Seth LoveJournal of Cellular and Molecular Medicine|July 28, 2011
Activators and inhibitors of the plasminogen system in Alzheimer's diseaseRachel Barker, Patrick G Kehoe, Seth LoveAlzheimer'S Research & Therapy|December 31, 2020
Cognitive impact of COVID-19: looking beyond the short termScott Miners, Patrick G Kehoe, Seth LoveJournal of Alzheimer'S Disease : JAD|May 1, 2013
Endothelin-converting enzyme-1 activity, endothelin-1 production, and free radical-dependent vasoconstriction in Alzheimer's diseaseJennifer C Palmer, Hannah M Tayler, Seth LoveBrain Pathology (Zurich, Switzerland)|September 28, 2004
The pathogenesis of neonatal post-hemorrhagic hydrocephalusShobha Cherian, Andrew Whitelaw, Marianne Thoresen, et al.Brain Research|September 18, 2010
Kallikrein-related peptidase 6 in Alzheimer's disease and vascular dementiaEmma L Ashby, Patrick G Kehoe, Seth LoveNeurobiology of Aging|November 16, 2010
Assessment of activation of the plasma kallikrein-kinin system in frontal and temporal cortex in Alzheimer's disease and vascular dementiaEmma L Ashby, Seth Love, Patrick G KehoeBrain Pathology (Zurich, Switzerland)|August 16, 2013
Convection-enhanced drug delivery to the brain: therapeutic potential and neuropathological considerationsNeil U Barua, Steven S Gill, Seth LovePageof 20